Search

… have worked very hard to achieve the start of our first clinical trial, so we were pleased to announce that we have started …

… year-end expected to fund operations through anticipated clinical data readouts in three different programs. First patient dosed in the Phase 1/2 safety & efficacy trial for QR-110 in children and adults with Leber’s … Positive results from the Phase 1b safety and tolerability clinical trial of eluforsen, formerly known as QR-010, in …

… Management provided an in-depth review of the Company’s clinical-stage programs and RNA editing technology platforms. … to report top-line results from the Phase 2/3 Illuminate trial in late Q1/early Q2 2022. The Illuminate  trial … from the Phase 1/2 Aurora trial for adRP with initial clinical data. A single dose of QR-1123 (gapmer) showed early …

… clinic in late 2024/early 2025 with translational data and trial design details to be announced in H2 2024 $4.5 million … advancing our first editing oligonucleotide programs to clinical stage, with AX-0810 targeting NTCP for cholestatic … translational data to be reported, and design for the clinical trial to be shared in H2 2024 with program to …

… the cost, timing and results of preclinical studies and clinical trials and other development activities by us and … partners; the likelihood of our preclinical and clinical programs being initiated and executed on timelines … timely enrollment of subjects and patients to advance our clinical trials and maintain their own operations; our …

… the cost, timing and results of preclinical studies and clinical trials and other development activities by us and … partners; the likelihood of our preclinical and clinical programs being initiated and executed on timelines … timely enrollment of subjects and patients to advance our clinical trials and maintain their own operations; our …

… the cost, timing and results of preclinical studies and clinical trials and other development activities by us and … or halted by the COVID-19 pandemic; the likelihood of our clinical programs being executed on timelines provided and … timely enrollment of subjects and patients to advance our clinical trials and maintain their own operations; our …

… year, we will share translational data and more about our clinical plans for AX-0810, as well preclinical proof of … translational data to be reported, and design for the clinical trial to be shared in H2 2024 with program to advance to the …

… development program for CF with presentation of positive clinical data at North American CF conference in October 2016 On track to report data from the ongoing Phase 1b trial of QR-010 in mid-2017 Finalizing preparations to start … the pipeline targeting dystrophic epidermolysis bullosa. Clinical trial to start and complete in 2018 LEIDEN, the …

… payloads, enhancing potency and durability to achieve clinical validation in patients faster. ProQR presentation … the cost, timing and results of preclinical studies, clinical trials and other development activities by us and … partners; the likelihood of our preclinical and clinical programs being initiated and executed on timelines …